CN Stock MarketDetailed Quotes
002007 Hualan Biological Engineering, Inc.
- 17.03
- -0.31-1.79%
Market Closed Dec 13 15:00 CST
31.14BMarket Cap23.27P/E (TTM)
17.33High17.00Low113.19KlotVolume17.33Open17.34Pre Close193.67MTurnover0.72%Turnover Ratio21.02P/E (Static)1.83BShares22.4552wk High2.66P/B26.80BFloat Cap13.7252wk Low19.07Limit Up1.57BShs Float74.90Historical High15.61Limit Down1.90%Amplitude-2.28Historical Low0.30Dividend TTM17.11Avg Price71.05KlotAsk1.76%Div YieldTTM100Lot Size40.76KlotBid
Hualan Biological Engineering, Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.79%3.49B | 4.26%1.65B | -10.60%787.31M | 18.26%5.34B | 8.62%3.91B | -32.53%1.59B | 37.46%880.66M | 1.82%4.52B | 7.18%3.6B | 82.32%2.35B |
| Operating revenue | -10.79%3.49B | 4.26%1.65B | -10.60%787.31M | 18.26%5.34B | 8.62%3.91B | -32.53%1.59B | 37.46%880.66M | 1.82%4.52B | 7.18%3.6B | 82.32%2.35B |
| Other operating revenue | ---- | 28.47%7.04M | ---- | -34.88%8.9M | ---- | -44.56%5.48M | ---- | 32.60%13.67M | ---- | 57.97%9.88M |
| Total operating cost | -4.27%2.43B | 14.42%1.26B | 0.11%544.58M | 10.02%3.42B | 3.01%2.54B | -33.72%1.1B | 39.47%543.96M | 14.66%3.11B | 20.51%2.47B | 93.76%1.66B |
| Operating cost | 12.32%1.33B | 27.48%814.93M | 7.27%348.95M | 5.98%1.62B | 0.11%1.19B | -15.57%639.26M | 28.71%325.31M | 10.53%1.53B | 14.53%1.19B | 46.48%757.18M |
| Operating tax surcharges | -15.00%28.47M | -15.11%17.39M | -25.09%8.37M | 6.89%44.62M | 0.78%33.49M | -11.68%20.48M | 71.58%11.17M | 15.42%41.75M | 27.97%33.23M | 61.54%23.19M |
| Operating expense | -31.11%615.73M | -23.26%122.31M | -29.27%44.73M | 29.33%1.2B | 10.50%893.76M | -73.06%159.38M | 384.19%63.24M | 19.93%929.71M | 31.50%808.85M | 651.96%591.72M |
| Administration expense | 20.26%249.83M | 23.66%165.21M | 11.21%72.76M | -3.59%274.29M | 0.45%207.74M | 2.02%133.6M | 29.60%65.42M | 12.22%284.49M | 7.37%206.81M | -0.15%130.95M |
| Financial expense | -680.02%-9.04M | -12,236.91%-8.26M | -335.35%-2.93M | -117.27%-1.67M | -114.58%-1.16M | -101.65%-66.99K | -64.10%1.25M | -1.33%9.68M | 151.71%7.95M | 143.29%4.05M |
| -Interest expense (Financial expense) | 22.37%11.38M | 31.44%8.21M | 20.38%4.5M | -56.48%13.17M | -62.12%9.3M | -60.36%6.24M | -53.25%3.74M | 39.32%30.27M | 100.05%24.54M | 162.73%15.75M |
| -Interest Income (Financial expense) | -92.94%-20.82M | -149.32%-16.75M | -132.24%-7.67M | 26.45%-15.43M | 35.48%-10.79M | 42.50%-6.72M | 27.17%-3.3M | -75.97%-20.97M | 23.26%-16.72M | 24.52%-11.68M |
| Research and development | -2.73%211.91M | -0.42%144.66M | -6.27%72.71M | -10.76%280.84M | -1.86%217.86M | -2.84%145.27M | 21.68%77.58M | 24.08%314.7M | 15.94%221.99M | 21.34%149.52M |
| Credit Impairment Loss | 128.38%7.3M | 3.10%41.94M | 61.69%33.92M | 57.58%-13.92M | 49.05%-25.73M | 214.73%40.68M | 41.15%20.98M | -190.83%-32.83M | -124.15%-50.51M | -204.52%-35.45M |
| Asset Impairment Loss | ---- | ---- | ---- | 42.22%-90.88M | --4.04M | --4.04M | --119.37K | -18.04%-157.3M | ---- | ---- |
| Other net revenue | -15.94%162.57M | -32.52%142.48M | -23.62%88.4M | 777.88%181.51M | 76.97%193.4M | 118.92%211.14M | 335.28%115.75M | 184.12%20.68M | 36.09%109.29M | -3.91%96.45M |
| Fair value change income | -50.23%23.63M | -45.20%19.36M | 1.68%9.46M | 67.68%60.54M | 78.17%47.47M | 78.59%35.32M | 551.82%9.31M | 34.43%36.11M | 129.14%26.65M | -53.85%19.78M |
| Invest income | -3.26%103.56M | -9.19%67.88M | 4.13%34.26M | 38.07%149.05M | 50.28%107.06M | 31.79%74.75M | 194.76%32.9M | 47.14%107.95M | -4.23%71.24M | 413.75%56.72M |
| -Including: Investment income associates | -5.69%-20.41M | 12.30%-13.45M | 34.87%-4.92M | 2.89%-25.64M | 8.00%-19.31M | -4.28%-15.34M | 25.62%-7.56M | -89.54%-26.41M | -384.97%-20.99M | -19.86%-14.71M |
| Asset deal income | -99.88%54.12K | -99.72%122.81K | -99.83%74.94K | -6.77%44.44M | -7.38%43.65M | -7.47%43.6M | 44,372.77%44.48M | 11,356.92%47.67M | 9,763.00%47.13M | 65,977.17%47.12M |
| Other revenue | 65.75%28.03M | 3.37%13.19M | 34.22%10.68M | 69.21%32.28M | 14.36%16.91M | 54.05%12.76M | 215.38%7.96M | -1.28%19.08M | -9.55%14.78M | -37.34%8.28M |
| Operating profit | -22.00%1.22B | -22.84%538.96M | -26.81%331.13M | 47.31%2.1B | 25.73%1.57B | -11.50%698.45M | 63.21%452.45M | -16.03%1.42B | -10.71%1.25B | 47.80%789.24M |
| Add:Non operating Income | 245.95%3.28M | 247.43%3.25M | -72.56%240.24K | -97.36%257.31K | -89.94%949.18K | -89.39%935.86K | 383.59%875.54K | 1,215.11%9.76M | 1,397.26%9.43M | 2,162.50%8.82M |
| Less:Non operating expense | 55.21%26.42M | -28.00%8.29M | 450.66%3M | 258.64%21M | 436.64%17.02M | 800.24%11.52M | 5.35%543.95K | -34.29%5.86M | -30.44%3.17M | -63.56%1.28M |
| Total profit | -22.69%1.2B | -22.38%533.92M | -27.48%328.38M | 45.46%2.08B | 23.82%1.55B | -13.67%687.87M | 63.53%452.78M | -15.39%1.43B | -10.00%1.25B | 50.08%796.78M |
| Less:Income tax cost | -32.57%187.6M | -32.30%85.14M | -23.30%54M | 74.79%315.96M | 48.52%278.22M | 7.67%125.77M | 62.50%70.41M | -22.79%180.76M | -6.02%187.33M | 44.19%116.81M |
| Net profit | -20.52%1.01B | -20.16%448.78M | -28.24%274.37M | 41.21%1.76B | 19.47%1.27B | -17.33%562.11M | 63.72%382.37M | -14.20%1.25B | -10.67%1.06B | 51.15%679.97M |
| Net profit from continuing operation | -20.52%1.01B | -20.14%448.88M | -28.24%274.37M | 41.21%1.76B | 19.47%1.27B | -17.33%562.11M | 63.72%382.37M | -14.20%1.25B | -10.67%1.06B | 51.15%679.97M |
| Net income from discontinuing operating | ---100.5K | ---100.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Minority Profit | -57.31%87.5M | -75.80%8.58M | -58.95%12.6M | 63.48%280.11M | 24.74%204.99M | -63.44%35.45M | 9,724.66%30.69M | 10.38%171.34M | 24.71%164.33M | 1,407.99%96.98M |
| Net profit of parent company owners | -13.46%923.66M | -16.42%440.2M | -25.56%261.77M | 37.66%1.48B | 18.51%1.07B | -9.66%526.65M | 50.37%351.68M | -17.14%1.08B | -15.07%900.6M | 27.49%582.99M |
| Earning per share | ||||||||||
| Basic earning per share | -13.57%0.5056 | -16.66%0.2406 | -25.78%0.1431 | 37.71%0.8121 | 18.45%0.585 | -9.72%0.2887 | 50.16%0.1928 | -17.33%0.5897 | -15.18%0.4939 | 27.51%0.3198 |
| Diluted earning per share | -13.79%0.5043 | -16.87%0.24 | -25.78%0.1431 | 37.92%0.8121 | 18.71%0.585 | -9.53%0.2887 | 50.51%0.1928 | -17.00%0.5888 | -15.37%0.4928 | 27.03%0.3191 |
| Other composite income | ||||||||||
| Total composite income | -20.52%1.01B | -20.16%448.78M | -28.24%274.37M | 41.21%1.76B | 19.47%1.27B | -17.33%562.11M | 63.72%382.37M | -14.20%1.25B | -10.67%1.06B | 51.15%679.97M |
| Total composite income of parent company owners | -13.46%923.66M | -16.42%440.2M | -25.56%261.77M | 37.66%1.48B | 18.51%1.07B | -9.66%526.65M | 50.37%351.68M | -17.14%1.08B | -15.07%900.6M | 27.49%582.99M |
| Total composite income of minority owners | -57.31%87.5M | -75.80%8.58M | -58.95%12.6M | 63.48%280.11M | 24.74%204.99M | -63.44%35.45M | 9,724.66%30.69M | 10.38%171.34M | 24.71%164.33M | 1,407.99%96.98M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
